ags 9Aicardi-Goutieres syndrome-9 (AGS9) is a type I interferonopathy characterized by severe developmental delay and progressive neurologic deterioration. Patients present in infancy withAGS 9 was amended in April 2019. These amendments are effective for audits of financial statements for periods beginning on or after 1 April 2018. Illustration